| Global and regional estimates of COPD prevalence: Systematic review and meta–analysis D Adeloye, S Chua, C Lee, C Basquill, A Papana, E Theodoratou, H Nair, ... Journal of global health 5 (2), 2015 | 1610 | 2015 |
| Barriers to improvement of mental health services in low-income and middle-income countries B Saraceno, M van Ommeren, R Batniji, A Cohen, O Gureje, J Mahoney, ... The Lancet 370 (9593), 1164-1174, 2007 | 1308 | 2007 |
| Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe E Han, MMJ Tan, E Turk, D Sridhar, GM Leung, K Shibuya, N Asgari, J Oh, ... The Lancet 396 (10261), 1525-1534, 2020 | 875 | 2020 |
| Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola S Moon, D Sridhar, MA Pate, AK Jha, C Clinton, S Delaunay, V Edwin, ... The Lancet 386 (10009), 2204-2221, 2015 | 647 | 2015 |
| SARS-CoV-2 variants and ending the COVID-19 pandemic A Fontanet, B Autran, B Lina, MP Kieny, SSA Karim, D Sridhar The Lancet 397 (10278), 952-954, 2021 | 620 | 2021 |
| Global health funding: how much, where it comes from and where it goes D McCoy, S Chand, D Sridhar Health policy and planning 24 (6), 407-417, 2009 | 359 | 2009 |
| Scientific consensus on the COVID-19 pandemic: we need to act now NA Alwan, RA Burgess, S Ashworth, R Beale, N Bhadelia, D Bogaert, ... The Lancet 396 (10260), e71-e72, 2020 | 345 | 2020 |
| Prevalence of rheumatoid arthritis in low–and middle–income countries: A systematic review and analysis I Rudan, S Sidhu, A Papana, SJ Meng, Y Xin–Wei, W Wang, ... Journal of global health 5 (1), 2015 | 320 | 2015 |
| Achieving global targets for antimicrobial resistance R Laxminarayan, D Sridhar, M Blaser, M Wang, M Woolhouse Science 353 (6302), 874-875, 2016 | 317 | 2016 |
| Misfinancing global health: a case for transparency in disbursements and decision making D Sridhar, R Batniji The Lancet 372 (9644), 1185-1191, 2008 | 295 | 2008 |
| SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties M Oliu-Barton, BSR Pradelski, P Aghion, P Artus, I Kickbusch, JV Lazarus, ... The Lancet 397 (10291), 2234-2236, 2021 | 210 | 2021 |
| The normative authority of the World Health Organization LO Gostin, D Sridhar, D Hougendobler Public Health 129 (7), 854-863, 2015 | 141 | 2015 |
| Governing global health: Who runs the world and why? C Clinton, DL Sridhar Oxford University Press, 2017 | 133 | 2017 |
| Who sets the global health research agenda? The challenge of multi-bi financing D Sridhar Public Library of Science 9 (9), e1001312, 2012 | 133 | 2012 |
| Government responses and COVID-19 deaths: Global evidence across multiple pandemic waves T Hale, N Angrist, AJ Hale, B Kira, S Majumdar, A Petherick, T Phillips, ... PloS one 16 (7), e0253116, 2021 | 132 | 2021 |
| Bridging the divide: global governance of trade and health K Lee, D Sridhar, M Patel The Lancet 373 (9661), 416-422, 2009 | 127 | 2009 |
| COVID-19 in Germany and China: mitigation versus elimination strategy G Lu, O Razum, A Jahn, Y Zhang, B Sutton, D Sridhar, K Ariyoshi, ... Global health action 14 (1), 1875601, 2021 | 119 | 2021 |
| Global governance of antimicrobial resistance C Rochford, D Sridhar, N Woods, Z Saleh, L Hartenstein, H Ahlawat, ... The Lancet 391 (10134), 1976-1978, 2018 | 119 | 2018 |
| Trojan multilateralism: global cooperation in health D Sridhar, N Woods Global Policy 4 (4), 325-335, 2013 | 115 | 2013 |
| Urbanization and prevalence of type 2 diabetes in Southern Asia: A systematic analysis A Cheema, D Adeloye, S Sidhu, D Sridhar, KY Chan Journal of global health 4 (1), 2014 | 112 | 2014 |